TEKCAPITAL PLC

Declaration of Voting Results & Voting Rights Announcements • Sep 7, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0976A

Tekcapital plc

07 September 2018

Tekcapital plc

Appointment of Joint Broker

Tekcapital plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from university technology, is pleased to announce that Novum Securities has been appointed as Joint Broker to the Company with immediate effect.

For further information please contact:       

Tekcapital plc Clifford M Gross, Ph.D	Via Walbrook PR
finnCap Ltd (Nominated Adviser and Joint Broker)	+44 (0) 20 7220 0500
Geoff Nash (Corporate Finance)
Max Bullen-Smith (Corporate Finance)
Alice Lane (ECM)

Novum Securities Limited (Joint Broker)	+44 (0) 20 7399 9427
Colin Rowbury (Corporate Broking)
Walbrook PR Ltd	+44 (0) 20 7933 8780
Paul Cornelius / Helen Cresswell / Sam Allen		tekcapital@walbrookpr.com

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPFKODPPBKKKCK